Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 1 - 50 av 92 resultater
Tid
Selskap
Tittel
Sektor
Kategori
18 Jun 2024
07:00 CEST
EUROAPI SA
EUROAPI and Priothera enter into CDMO collaboration to advance oncology project
20103015 Pharmaceuticals
Other subject
18 Jun 2024
07:00 CEST
EUROAPI SA
EUROAPI et Priothera signent un accord de CDMO pour un projet en oncologie
20103015 Pharmaceuticals
Other subject
06 Jun 2024
17:53 CEST
EUROAPI SA
Information marché Financement du projet de transformation FOCUS-27
20103015 Pharmaceuticals
Other subject
06 Jun 2024
17:53 CEST
EUROAPI SA
Market update : FOCUS-27 transformation project financing
20103015 Pharmaceuticals
Other subject
06 Jun 2024
07:00 CEST
EUROAPI SA
EUROAPI franchit une étape majeure du PIIEC Santé avec la notification officielle de la Commission européenne
20103015 Pharmaceuticals
Other subject
06 Jun 2024
07:00 CEST
EUROAPI SA
EUROAPI reaches major Health IPCEI milestone with official notification from European Commission
20103015 Pharmaceuticals
Other subject
23 May 2024
07:00 CEST
EUROAPI SA
EUROAPI renforce sa présence en santé animale avec un contrat de fourniture de 130-150 millions d’euros
20103015 Pharmaceuticals
Other subject
23 May 2024
07:00 CEST
EUROAPI SA
EUROAPI strengthens its presence in animal health with a €130-150 million supply contract
20103015 Pharmaceuticals
Other subject
22 May 2024
17:45 CEST
EUROAPI SA
Combined General Meeting of May 22, 2024
20103015 Pharmaceuticals
Other subject
22 May 2024
17:45 CEST
EUROAPI SA
Assemblée Générale Mixte du 22 mai 2024
20103015 Pharmaceuticals
Other subject
13 May 2024
18:00 CEST
EUROAPI SA
Evelyne Nguyen appointed EUROAPI’s Chief Financial Officer
20103015 Pharmaceuticals
Other subject
13 May 2024
18:00 CEST
EUROAPI SA
Evelyne Nguyen est nommée Directrice financière d’EUROAPI
20103015 Pharmaceuticals
Other subject
30 Apr 2024
07:00 CEST
EUROAPI SA
Combined General Meeting of May 22, 2024 - Availability of preparatory documents
20103015 Pharmaceuticals
Other subject
30 Apr 2024
07:00 CEST
EUROAPI SA
Assemblée Générale mixte du 22 mai 2024 - Modalités de mise à disposition ou de consultation des documents préparatoires
20103015 Pharmaceuticals
Other subject
09 Apr 2024
18:18 CEST
EUROAPI SA
EUROAPI streamlines its Executive Committee to improve focus and efficiency
20103015 Pharmaceuticals
Other subject
09 Apr 2024
18:18 CEST
EUROAPI SA
EUROAPI resserre son Comité exécutif afin de se recentrer et de gagner en efficacité
20103015 Pharmaceuticals
Other subject
05 Apr 2024
18:20 CEST
EUROAPI SA
Availability of the 2023 Universal Registration Document, including the Annual Financial Report
20103015 Pharmaceuticals
Other subject
05 Apr 2024
18:20 CEST
EUROAPI SA
Mise à disposition du Document d’Enregistrement Universel 2023, contenant le Rapport Financier Annuel
20103015 Pharmaceuticals
Other subject
28 Mar 2024
07:00 CET
EUROAPI SA
Document d’Enregistrement Universel 2023
20103015 Pharmaceuticals
Other subject
28 Mar 2024
07:00 CET
EUROAPI SA
2023 Universal Registration Document
20103015 Pharmaceuticals
Other subject
14 Mar 2024
18:55 CET
EUROAPI SA
Perspectives 2024 suspendues à la suite de l’arrêt temporaire de production d’API sur le site de Brindisi en Italie
20103015 Pharmaceuticals
Other subject
14 Mar 2024
18:55 CET
EUROAPI SA
Full-year 2024 guidance suspended due to the temporary pause of API production at the Brindisi site in Italy
20103015 Pharmaceuticals
Other subject
28 Feb 2024
19:16 CET
EUROAPI SA
Résultats annuels 2023
20103015 Pharmaceuticals
Other subject
28 Feb 2024
19:16 CET
EUROAPI SA
Full-year 2023 results
20103015 Pharmaceuticals
Other subject
25 Jan 2024
07:00 CET
EUROAPI SA
EUROAPI Enhances Its CDMO Capabilities Through a Pivotal Collaboration With SpiroChem, a Leading Contract Research Organization (CRO)
20103015 Pharmaceuticals
Other subject
25 Jan 2024
07:00 CET
EUROAPI SA
EUROAPI enrichit ses compétences en CDMO grâce à une collaboration essentielle avec SpiroChem, une Contract Research Organization (CRO) de premier plan
20103015 Pharmaceuticals
Other subject
04 Jan 2024
17:45 CET
EUROAPI SA
EUROAPI renforce son Comité Exécutif en nommant Ludwig de Mot Directeur Général Adjoint, en charge de la transformation de l’entreprise
20103015 Pharmaceuticals
Other subject
04 Jan 2024
17:45 CET
EUROAPI SA
EUROAPI Strengthens its Executive Committee with the Appointment of Ludwig de Mot as Executive Vice President - Chief Transformation Officer
20103015 Pharmaceuticals
Other subject
28 Nov 2023
08:00 CET
EUROAPI SA
EUROAPI Appoints New Executive Committee Members
20103015 Pharmaceuticals
Other subject
28 Nov 2023
08:00 CET
EUROAPI SA
EUROAPI nomme de nouveaux membres au Comité Exécutif
20103015 Pharmaceuticals
Other subject
21 Nov 2023
17:45 CET
EUROAPI SA
CDMO : EUROAPI finalise l’acquisition de Biano
20103015 Pharmaceuticals
Other subject
21 Nov 2023
17:45 CET
EUROAPI SA
CDMO: EUROAPI Completes Acquisition of Biano
20103015 Pharmaceuticals
Other subject
30 Oct 2023
18:38 CET
EUROAPI SA
EUROAPI: Information Relating to the Financial Terms of the Departure of the Chief Executive Officer and the Appointment of the Chairman of the Board as Interim Chief Executive Officer
20103015 Pharmaceuticals
Other subject
30 Oct 2023
18:38 CET
EUROAPI SA
EUROAPI : Information relative aux conditions financières du départ du Directeur Général et de la nomination de la Présidente du Conseil d’Administration comme Directrice Générale par intérim
20103015 Pharmaceuticals
Other subject
25 Oct 2023
18:15 CEST
EUROAPI SA
Nouvelle gouvernance chez EUROAPI
20103015 Pharmaceuticals
Other subject
25 Oct 2023
18:15 CEST
EUROAPI SA
EUROAPI Announces New Governance
20103015 Pharmaceuticals
Other subject
24 Oct 2023
17:45 CEST
EUROAPI SA
EUROAPI Increases the Resources Allocated to the Liquidity Contract With Kepler Cheuvreux
20103015 Pharmaceuticals
Other subject
24 Oct 2023
17:45 CEST
EUROAPI SA
EUROAPI : Augmentation des moyens affectés au contrat de liquidité conclu avec Kepler Cheuvreux
20103015 Pharmaceuticals
Other subject
09 Oct 2023
17:45 CEST
EUROAPI SA
EUROAPI: Full-Year 2023 Outlook Revised Downwards
20103015 Pharmaceuticals
Other subject
09 Oct 2023
17:45 CEST
EUROAPI SA
EUROAPI : Objectifs 2023 revus à la baisse
20103015 Pharmaceuticals
Other subject
29 Aug 2023
07:00 CEST
EUROAPI SA
EUROAPI to Acquire BianoGMP to Strengthen its CDMO Expertise in the High-Growth oligonucleotide Market
20103015 Pharmaceuticals
Other subject
29 Aug 2023
07:00 CEST
EUROAPI SA
EUROAPI va acquérir BianoGMP pour renforcer son expertise CDMO sur le marché en forte croissance des oligonucléotides
20103015 Pharmaceuticals
Other subject
02 Aug 2023
17:45 CEST
EUROAPI SA
EUROAPI : Mise à disposition du Rapport financier semestriel 2023
20103015 Pharmaceuticals
Corporate life
02 Aug 2023
17:45 CEST
EUROAPI SA
EUROAPI: Availability of 2023 Half-Year Financial Report
20103015 Pharmaceuticals
Corporate life
01 Aug 2023
07:00 CEST
EUROAPI SA
EUROAPI: H1 2023 RESULTS
20103015 Pharmaceuticals
Other subject
01 Aug 2023
07:00 CEST
EUROAPI SA
EUROAPI : RESULTATS SEMESTRIELS 2023
20103015 Pharmaceuticals
Other subject
13 Jun 2023
13:55 CEST
EUROAPI SA
Health Sovereignty: EUROAPI Supports the Supply of Essential Medicines to France and Europe
20103015 Pharmaceuticals
Other subject
13 Jun 2023
13:55 CEST
EUROAPI SA
Souveraineté sanitaire : EUROAPI se mobilise en faveur de l’approvisionnement de la France et de l’Europe en médicaments essentiels
20103015 Pharmaceuticals
Other subject
06 Jun 2023
17:45 CEST
EUROAPI SA
EUROAPI to Invest €50 Million at Its Budapest Site to Meet the Growing Demand for Prostaglandins
20103015 Pharmaceuticals
Other subject
06 Jun 2023
17:45 CEST
EUROAPI SA
EUROAPI va investir 50 millions d’euros sur son site de Budapest pour répondre à la demande croissante de prostaglandines
20103015 Pharmaceuticals
Other subject
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
1
2
›
››
»
Last »
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva